![Kris Verburgh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Kris Verburgh is the founder of Novos, which was founded in 2020.
He is currently a Venture Partner at Longevity Vision Fund since 2019.
Mr. Verburgh graduated from the University of Antwerp in 2011.
Cargos activos de Kris Verburgh
Empresas | Cargo | Inicio |
---|---|---|
Longevity Vision Fund
![]() Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Inversor de Capital Privado | 01/03/2019 |
Novos
![]() Novos Packaged SoftwareTechnology Services Novos is a public benefit corporation that develops science-based solutions to slow down human aging. The company was founded by Chris Mirabile, Kris Verburgh, and is based in New York, NY. The company is the first supplement targeting aging at the root cause and address 12 hallmarks of aging for optimal longevity and lifespan. Novos offers the first anti-aging supplements in the world based on the best available science to address aging. Chris Mirabile has been the CEO since incorporation. | Fundador | 01/01/2020 |
Formación de Kris Verburgh.
University of Antwerp | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Longevity Vision Fund
![]() Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund (Longevity Vision Fund) is a venture capital firm founded in 2018 by Sergey Young. The firm is headquartered in New York. | Finance |
Novos
![]() Novos Packaged SoftwareTechnology Services Novos is a public benefit corporation that develops science-based solutions to slow down human aging. The company was founded by Chris Mirabile, Kris Verburgh, and is based in New York, NY. The company is the first supplement targeting aging at the root cause and address 12 hallmarks of aging for optimal longevity and lifespan. Novos offers the first anti-aging supplements in the world based on the best available science to address aging. Chris Mirabile has been the CEO since incorporation. | Technology Services |
- Bolsa de valores
- Insiders
- Kris Verburgh